Trials / Sponsors / Inhibikase Therapeutics
Inhibikase Therapeutics
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) Pulmonary Arterial Hypertension | Phase 3 | 2026-03-01 |
| Withdrawn | A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH) Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) | Phase 2 | 2025-06-30 |
| Completed | A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg CML | Phase 1 | 2022-12-16 |